ASCO Genitourinary Cancers Symposium
ASCO GU 2022 on 1L Axitinib + Pembro in Advanced RCC: Real-World Treatment Outcomes in the United States
By
ASCO Genitourinary Cancers Symposium
FEATURING
Yousef Zakharia
By
ASCO Genitourinary Cancers Symposium
FEATURING
Yousef Zakharia
Login to view comments.
Click here to Login